Gobbi C, et al. Real-world data from the TACO (teriflunomide in relapsing remitting multiple sclerosis patients assessing clinical benefit and patient-reported outcomes) study. Poster 1371. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Alzheimer Nederland steunt 6 talentvolle onderzoekers met ruim 1,7 miljoen
jan 2022 | Dementie